Merck Income from Continuous Operations 2010-2024 | MRK

Merck income from continuous operations for the twelve months ending June 30, 2024 was $13.752B, a 340.35% increase year-over-year.

  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $14.526B, a 17.54% increase from 2021.
  • Merck annual income from continuous operations for 2021 was $12.358B, a 173.23% increase from 2020.

Merck Income from Continuous Operations 2010-2024 | MRK

  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $14.526B, a 17.54% increase from 2021.
  • Merck annual income from continuous operations for 2021 was $12.358B, a 173.23% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M